GLAND₹2,826.80-0.83%
Value & Investment Index
VIIVII Detail
90 days · zone the stock traded inMultiples vs Peers
Quality Scores
Versus Its Own History
P/E · P/B percentile bandsScenario analysis
stated assumptions, shown workingsGLAND valuation summary
Gland Pharma Ltd trades at 35.6 times trailing earnings. Return on equity is 12.8% and return on capital employed is 17.4%. The dividend yield is 0.66%.
| P/E | 35.6 |
|---|---|
| ROE | 12.8% |
| ROCE | 17.4% |
| Dividend yield | 0.66% |